This study looked at two different ways to offer genetic testing to people diagnosed with hypertrophic or dilated cardiomyopathy, which are conditions that affect the heart muscle. One approach, called 'mainstreaming,' offered testing directly in cardiology clinics. The other approach was the traditional referral to a Medical Genetics service, where patients could attend a webinar or a one-on-one counseling appointment.
The researchers found that when testing was offered in the cardiology clinic, more patients chose to get tested (82% vs. 69%) and they waited much less time—sometimes over three to six months less. However, a key finding was that only 62% of patients in the clinic pathway were considered to have made a fully informed decision, compared to 91% of those who attended the Medical Genetics webinar.
Patient satisfaction with their decision was high in both groups. The study did not report on any safety concerns. It's important to be careful because this was an observational study, which means it can show a link between the testing pathway and the outcomes, but it cannot prove that one caused the other. The sample size and specific time period were also not fully reported. For patients, this research suggests that getting genetic testing in a cardiology clinic can be faster and more accessible, but it highlights the crucial need for good education to help people understand their choices fully.
